- Home
- JHS vs INO Comparison
JHS vs INO Comparison
Compare JHS & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHS
- INO
- Stock Information
- Founded
- JHS 1973
- INO 1979
- Country
- JHS United States
- INO United States
- Employees
- JHS N/A
- INO 134
- Industry
- JHS Finance Companies
- INO Medical/Dental Instruments
- Sector
- JHS Finance
- INO Health Care
- Exchange
- JHS Nasdaq
- INO Nasdaq
- Market Cap
- JHS 131.4M
- INO 136.0M
- IPO Year
- JHS N/A
- INO 1998
- Fundamental
- Price
- JHS $11.94
- INO $2.59
- Analyst Decision
- JHS
- INO Buy
- Analyst Count
- JHS 0
- INO 5
- Target Price
- JHS N/A
- INO $8.80
- AVG Volume (30 Days)
- JHS 32.8K
- INO 1.1M
- Earning Date
- JHS 01-01-0001
- INO 11-13-2025
- Dividend Yield
- JHS 3.96%
- INO N/A
- EPS Growth
- JHS N/A
- INO N/A
- EPS
- JHS 0.02
- INO N/A
- Revenue
- JHS N/A
- INO $182,337.00
- Revenue This Year
- JHS N/A
- INO N/A
- Revenue Next Year
- JHS N/A
- INO $15,960.33
- P/E Ratio
- JHS $553.50
- INO N/A
- Revenue Growth
- JHS N/A
- INO N/A
- 52 Week Low
- JHS $9.76
- INO $1.30
- 52 Week High
- JHS $11.25
- INO $5.83
- Technical
- Relative Strength Index (RSI)
- JHS 65.87
- INO 59.34
- Support Level
- JHS $11.70
- INO $2.28
- Resistance Level
- JHS $12.09
- INO $2.68
- Average True Range (ATR)
- JHS 0.13
- INO 0.15
- MACD
- JHS 0.01
- INO -0.01
- Stochastic Oscillator
- JHS 68.37
- INO 71.60
About JHS John Hancock Income Securities Trust
John Hancock Income Securities Trust is a United States-based closed-ended diversified management investment company. Its primary objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.